Alar Pharmaceuticals Inc. (TPEX:6785)
Taiwan · Delayed Price · Currency is TWD 121.00
+1.50 (1.26%)
Jun 18, 2026, 1:30 PM CST
Alar Pharmaceuticals Market Cap
Alar Pharmaceuticals has a market cap or net worth of 8.08 billion as of June 18, 2026. Its market cap has decreased by -13.57% in one year.
Market Cap
8.08B
Enterprise Value
5.78B
Revenue
3.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
121.00
Market Cap Chart
Since October 5, 2020, Alar Pharmaceuticals's market cap has increased from 2.57B to 8.08B, an increase of 215.12%. That is a compound annual growth rate of 22.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 8.08B | -60.20% |
| Dec 31, 2025 | 20.31B | 114.84% |
| Dec 31, 2024 | 9.45B | -20.85% |
| Dec 29, 2023 | 11.94B | 82.17% |
| Dec 30, 2022 | 6.56B | 151.37% |
| Dec 30, 2021 | 2.61B | -6.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ScinoPharm Taiwan | 16.25B |
| Synmosa Biopharma | 15.47B |
| YungShin Global Holding | 15.16B |
| Grape King Bio | 14.77B |
| Handa Pharmaceuticals | 13.62B |
| Foresee Pharmaceuticals | 12.35B |
| Standard Chemical & Pharmaceutical | 11.24B |
| Formosa Laboratories | 6.29B |